DelveInsight’s, “Systemic Mastocytosis Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

There are gaps in SM diagnostics and researchers believe there would be advantages to implementing a system-wide screening algorithm. Nonadvanced systemic mastocytosis, which includes bone marrow ...

During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...

Fintel reports that on June 17, 2025, Wells Fargo downgraded their outlook for Blueprint Medicines (NasdaqGS:BPMC) from ...

Andembry (garadacimab) can help people with hereditary angioedema prevent potentially serious swelling attacks. The FDA has approved Andembry (garadacimab), a once-monthly injection, to prevent ...

Verve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will ...

Most areas of allergy and clinical immunology still require further research and investigation. There are some specific conditions, such as hereditary angioedema and mastocytosis, that have ...